Article Figures & Data
Figures
- Figure 1 AQP4-IgG–Positive Serum Samples Show Stronger Complement Activation Than MOG-IgG–Positive Serum Samples
(A) CDC (shown as percentage of lysis buffer determined by the LDH assay) of 68 MOG-IgG–positive human serum samples (blue circles; MOGα1-EGFP–transfected cells) and 39 AQP4-IgG–positive human serum samples (red triangles; AQP4-M23-EmGFP–transfected cells) is plotted against the antibody titers. Semi-log linear regression lines are shown. Spearman correlation: MOG: r = 0.58, p < 0.0001; AQP4: r = 0.71, p < 0.0001. (B) Violin plot (dashed line: median, dotted lines: quartiles) of all MOG-IgG (blue; n = 68) and AQP4-IgG (red; n = 39) positive serum samples tested is shown. Asterisks indicate the statistical difference of a Mann-Whitney test: ****p < 0.0001. The solid lines indicate the cutoff levels (mean + 2SD of cells treated with complement alone). (C) Percentage of MOG-IgG (blue) or AQP4-IgG (red) positive samples above the cutoff level (mean + 2SD of cells treated with complement alone) is demonstrated as bar graph. (D) The predictive role of MOG-IgG and AQP4-IgG antibody titers and status, age, and sex on complement-dependent cell lysis were analyzed by multivariate regression (R = 0.827, R2 = 0.684, F = 53.1, p < 0.001). Standardized regression coefficient beta is shown with 95% CI. ***p < 0.001. AQP4 = aquaporin-4; CDC = complement-dependent cytotoxicity; LB = lysis buffer; MOG = myelin oligodendrocyte glycoprotein.
- Figure 2 Complement Activation on Different MOG Isoforms
(A) Comparison of CDC (as percentage of lysis buffer) of MOG-IgG–positive serum samples (n = 68) with 6 different MOG isoforms (MOGα1-3 and MOGβ1-3) is shown as a scatter dot plot. Bars indicate medians with interquartile range (Friedman test with post hoc Dunn: *p < 0.05, ***p < 0.001, and ****p < 0.0001). The solid line indicates the cutoff level (mean + 2SD of cells treated with complement alone). (B) Shows the percentage of MOG-IgG–positive serum samples above the cutoff value (mean + 2SD of cells treated with complement alone) for the 6 MOG isoforms. The percentages are plotted according to their respective binding patterns (α1β1, α1-3β1, and α1-3β1-3; values are given within the bars). AQP4 = aquaporin-4; LB = lysis buffer; MOG = myelin oligodendrocyte glycoprotein.
- Figure 3 Quantification of TCC Deposition
TCC deposition after complement activation of either MOGα1-EGFP (blue) or AQP4-EmGFP (red) transfected HEK293A cells by MOG-IgG or AQP4-IgG–positive serum samples together with human complement was quantified using an flow cytometry assay. (A) Mean fluorescence intensity (MFI) values are plotted against the antibody titers. The lines show semi-log linear regression. Spearman correlation: MOG: r = 0.56, p < 0.05, n = 19; AQP4: r = 0.77, p < 0.001, n = 19. (B) Comparison of MFI values between MOG (n = 19) and AQP4 (n = 19) is shown as violin plot (dashed line: median, dotted lines: quartiles). Mann-Whitney test: **p = 0.002. (C) The MFI values of TCC deposition of human sera are plotted against the respective values from the LDH assay (see Figure 1). Spearman correlation: MOG: r = 0.48, p < 0.05, n = 19; AQP4: r = 0.57, p < 0.05, n = 19. AQP4 = aquaporin-4; LDH = lactate dehydrogenase; MFI = mean fluorescence intensity; MOG = myelin oligodendrocyte glycoprotein; TCC = terminal complement complex.
Tables
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
